After fraud settlement, Kirk decided to pay insurance CEO $21.5 million
By Kevin Connor  •  Sep 24, 2009 at 11:42 EST

The same year that Hartford Insurance settled a $20 million fraud suit with the state of New York, board member and compensation chair Paul Kirk decided to make the company’s CEO the second-highest paid executive in the insurance industry.

Today, Kirk was named Kennedy’s successor in the Senate by Massachusetts governor Deval Patrick.

Sunlight’s Paul Blumenthal detailed Paul Kirk’s corporate ties in a post this morning, highlighting his role on Hartford Financial Services’ compensation committee and his past lobbying work for Aventis pharmaceuticals. He also noted that Kirk helped make CEO Ramani Ayer one of the most overpaid executives in the country, according to Forbes, with compensation of $9 million in 2008. The New York Times chose to report exactly none of this in an article posted this afternoon.

The Hartford is an insurance company, so it wasn’t very hard to find areas where they’ve run afoul of the law. Seriously: google “Hartford Financial” fraud. There you have it: in 2006, the company agreed to pay $20 million to settle an investigation by New York and Connecticut into fraudulent sales of retirement products:

Read more…

Possible successor to Kennedy is top pharma lobbyist
By Kevin Connor  •  Sep 18, 2009 at 13:18 EST

A possible candidate for Senator Kennedy’s seat has spent the last ten years building the biggest pharmaceutical lobbying practice in the country.

Nick Littlefield is chair of the lobbying group at Boston law firm Foley Hoag, which has raced to the top of the pharma lobbying charts over the last several years. In the first half of 2009, the firm raked in $2.6 million from pharma — more lobbying cash from pharmaceutical interests over the course of six months than any law firm in history, according to a review of lobbying data from Open Secrets.

Read more…